ISSAQUAH, Wash.--()--Spacelabs Healthcare, the inventor of Holter technology, and whose ambulatory blood pressure (ABP) monitors are widely recognized as today’s “gold standard,” will exhibit its latest solutions next week at the American Heart Association’s Scientific Sessions meeting in Los Angeles.
“Pathfinder represents a significant advancement in exploring a patient’s cardiac condition – with speed, accuracy and control”
At the forefront will be Pathfinder SL – a new Holter Analyzer combining leading edge technology and advanced algorithms to provide full analysis for up to seven days of continuous recording, in one analysis process and one report. Pathfinder SL provides fast and accurate results in even the most complex, noisy or unstable recordings.
“Pathfinder represents a significant advancement in exploring a patient’s cardiac condition – with speed, accuracy and control,” said Nicholas Ong, President of Spacelabs Healthcare.
Spacelabs will also highlight Sentinel, a cardiology information management system that integrates reports from Spacelabs’ entire range of noninvasive diagnostic cardiology solutions – Holter monitoring, ambulatory blood pressure monitoring, 12-lead ECG, and ECG stress testing – then organizes and stores this data in a central networked database for fast, easy access.
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com), a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the performance of the Company’s products. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.